kabutan

KNC Laboratories Co., Ltd.(6568) Summary

6568
TSE Growth
KNC Laboratories Co., Ltd.
1,272
JPY
-8
(-0.63%)
Apr 30, 9:20 am JST
7.94
USD
Apr 29, 8:20 pm EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
16.4
PBR
0.74
Yield
2.59%
Margin Trading Ratio
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
1,255 JPY 7.83 USD
Previous Close Apr 28
1,280 JPY 8.03 USD
High Apr 30, 9:20 am
1,272 JPY 7.94 USD
Low Apr 30, 9:00 am
1,255 JPY 7.83 USD
Volume
900
Trading Value
1.00M JPY 7.05K USD
VWAP
1256.89 JPY 7.84 USD
Minimum Trading Value
127,200 JPY 794 USD
Market Cap
9.90B JPY 0.06B USD
Number of Trades
2
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
Slightly Low
1-Year Average
26
1-Year High Jan 21, 2026
505
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 116,500
Apr 17, 2026 0 111,400
Apr 10, 2026 0 112,700
Apr 3, 2026 0 113,500
Mar 27, 2026 0 113,900
Company Profile
KNC Laboratories Co., Ltd. specializes in contract research, development, and scale-up production of organic compounds, offering proprietary technologies in pharmaceuticals, functional materials, and biotechnology.
Sector
Services
KNC Laboratories Co., Ltd. primarily engages in research, development, and production solutions for organic chemicals. The company supplies samples and products necessary for customers' product development and sales, providing problem-solving services tailored to various development stages. Their main focus is on functional chemicals and intermediates used in pharmaceutical and information electronics fields. KNC offers comprehensive solutions from research to mass production stages, adapting services to meet customers' product development needs. Through its functional materials, pharmaceutical, and biotechnology divisions, the company handles display materials, semiconductor manufacturing chemicals, pharmaceutical active ingredients, raw materials for clinical trials, and additives for antibody drug manufacturing. By working closely with customers, KNC supports the improvement of product development efficiency and reduction of development timelines.